Recross Cardio, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluating Percutaneous Repair Of The Atrial Septum With A Novel PFO Occluder: The PROTEA-PFO OUS Study (NCT07698951) | Recross Cardio, Inc. | 2026-06-17 |
| Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study (NCT07172464) | Recross Cardio, Inc. | 2025-10-09 |
Track Recross Cardio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.